{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:14:54Z","timestamp":1789434894772,"version":"build-2803163510"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12035-021-02453-3","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T17:02:45Z","timestamp":1626282165000},"page":"5141-5162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5701-0694","authenticated-orcid":false,"given":"Melissa J.","family":"Alldred","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai C.","family":"Penikalapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Heguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Roussos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1797-4288","authenticated-orcid":false,"given":"Stephen D.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"2453_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/bdra.20735","volume":"88","author":"SE Parker","year":"2010","unstructured":"Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA et al (2010) Updated National Birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88:1008\u20131016","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"4","key":"2453_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","volume":"163","author":"AP Presson","year":"2013","unstructured":"Presson AP, Partyka G, Jensen KM, Devine OJ, Rasmussen SA, McCabe LL et al (2013) Current estimate of Down Syndrome population prevalence in the United States. J Pediatr 163(4):1163\u20131168","journal-title":"J Pediatr"},{"key":"2453_CR3","doi-asserted-by":"crossref","unstructured":"Mann DM, Yates PO, Marcyniuk B (1984) Alzheimer' s presenile dementia, senile dementia of Alzheimer type and Down' s syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 10:185\u2013207","DOI":"10.1111\/j.1365-2990.1984.tb00351.x"},{"issue":"9","key":"2453_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0166-2236(88)90075-6","volume":"11","author":"JT Coyle","year":"1988","unstructured":"Coyle JT, Oster-Granite ML, Reeves RH, Gearhart JD (1988) Down syndrome, Alzheimer ' s disease and the trisomy16 mouse. Trends Neurosci 11(9):390\u2013394","journal-title":"Trends Neurosci"},{"key":"2453_CR5","first-page":"1","volume":"311","author":"EB Hook","year":"1989","unstructured":"Hook EB (1989) Issues pertaining to the impact and etiology of trisomy 21 and other aneuploidy in humans; a consideration of evolutionary implications, maternal age mechanisms, and other matters. Prog Clin Biol Res 311:1\u201327","journal-title":"Prog Clin Biol Res"},{"issue":"1","key":"2453_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00001756-199310000-00005","volume":"5","author":"PS Hodgkins","year":"1993","unstructured":"Hodgkins PS, Prasher V, Farrar G, Armstrong R, Sturman S, Corbett J, Blair JA (1993) Reduced transferrin binding in Down syndrome: a route to senile plaque formation and dementia. Neuroreport. 5(1):21\u201324","journal-title":"Neuroreport."},{"issue":"7","key":"2453_CR7","first-page":"1283","volume":"17","author":"GM Roth","year":"1996","unstructured":"Roth GM, Sun B, Greensite FS, Lott IT, Dietrich RB (1996) Premature aging in persons with Down syndrome: MR findings. AJNR Am J Neuroradiol 17(7):1283\u20131289","journal-title":"AJNR Am J Neuroradiol"},{"key":"2453_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P","volume":"6","author":"RS Chapman","year":"2000","unstructured":"Chapman RS, Hesketh LJ (2000) Behavioral phenotype of individuals with Down syndrome. Ment Retard Dev Disabil Res Rev 6:84\u201395","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"2453_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer ' s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol 157:277\u2013286","journal-title":"Am J Pathol"},{"key":"2453_CR10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","volume":"11","author":"D Hartley","year":"2015","unstructured":"Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner K, Granholm AC, Iqbal K et al (2015) Down syndrome and Alzheimer ' s disease: common pathways, common goals. Alzheimers Dement 11:700\u2013709","journal-title":"Alzheimers Dement"},{"key":"2453_CR11","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1093\/brain\/awu173","volume":"137","author":"SL Hartley","year":"2014","unstructured":"Hartley SL, Handen BL, Devenny DA, Hardison R, Mihaila I, Price JC, Cohen AD, Klunk WE et al (2014) Cognitive functioning in relation to brain amyloid-beta in healthy adults with Down syndrome. Brain. 137:2556\u20132563","journal-title":"Brain."},{"key":"2453_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/exnr.1997.6777","volume":"150","author":"JB Leverenz","year":"1998","unstructured":"Leverenz JB, Raskind MA (1998) Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis. Exp Neurol 150:296\u2013304","journal-title":"Exp Neurol"},{"key":"2453_CR13","doi-asserted-by":"crossref","unstructured":"Wisniewski KE, Dalton AJ, Crapper McLachlan DR, Wen GY, Wisniewski HM (1985) Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology. 35:957\u2013961","DOI":"10.1212\/WNL.35.7.957"},{"issue":"8","key":"2453_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","volume":"46","author":"F Lai","year":"1989","unstructured":"Lai F, Williams RS (1989) A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46(8):849\u2013853","journal-title":"Arch Neurol"},{"issue":"3","key":"2453_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00401-019-01965-6","volume":"137","author":"SE Perez","year":"2019","unstructured":"Perez SE, Miguel JC, He B, Malek-Ahmadi M, Abrahamson EE, Ikonomovic MD, Lott I, Doran E et al (2019) Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia. Acta Neuropathol 137(3):413\u2013436","journal-title":"Acta Neuropathol"},{"key":"2453_CR16","doi-asserted-by":"crossref","unstructured":"Sendera TJ, Ma SY, Jaffar S, Kozlowski PB, Kordower JH, Mawal Y, Saragovi HU, Mufson EJ (2000) Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down' s syndrome. J Neurochem 74(3):1185\u20131196","DOI":"10.1046\/j.1471-4159.2000.741185.x"},{"key":"2453_CR17","doi-asserted-by":"crossref","unstructured":"Mufson EJ, Bothwell M, Kordower JH (1989) Loss of nerve growth factor receptor-containing neurons in Alzheimer' s disease: a quantitative analysis across subregions of the basal forebrain. Exp Neurol 105:221\u2013232","DOI":"10.1016\/0014-4886(89)90124-6"},{"key":"2453_CR18","doi-asserted-by":"crossref","unstructured":"Mann DM, Yates PO, Marcyniuk B, Ravindra CR (1986) The topography of plaques and tangles in Down' s syndrome patients of different ages. Neuropathol Appl Neurobiol 12:447\u2013457","DOI":"10.1111\/j.1365-2990.1986.tb00053.x"},{"key":"2453_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/cne.21895","volume":"512","author":"PV Belichenko","year":"2009","unstructured":"Belichenko PV, Kleschevnikov AM, Masliah E, Wu C, Takimoto-Kimura R, Salehi A, Mobley WC (2009) Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome. J Comp Neurol 512:453\u2013466","journal-title":"J Comp Neurol"},{"key":"2453_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cne.20337","volume":"480","author":"PV Belichenko","year":"2004","unstructured":"Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC (2004) Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. J Comp Neurol 480:281\u2013298","journal-title":"J Comp Neurol"},{"key":"2453_CR21","doi-asserted-by":"crossref","unstructured":"Granholm AC, Sanders LA, Crnic LS (2000) Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down' s syndrome. Exp Neurol 161:647\u2013663","DOI":"10.1006\/exnr.1999.7289"},{"key":"2453_CR22","doi-asserted-by":"crossref","unstructured":"Kelley CM, Powers BE, Velazquez R, Ash JA, Ginsberg SD, Strupp BJ, Mufson EJ (2014) Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer' s disease. Brain Pathol 24:33\u201344","DOI":"10.1111\/bpa.12073"},{"key":"2453_CR23","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/cne.23492","volume":"522","author":"CM Kelley","year":"2014","unstructured":"Kelley CM, Powers BE, Velazquez R, Ash JA, Ginsberg SD, Strupp BJ, Mufson EJ (2014) Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice. J Comp Neurol 522:1390\u20131410","journal-title":"J Comp Neurol"},{"issue":"9","key":"2453_CR24","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1093\/brain\/awz193","volume":"142","author":"MJ Betts","year":"2019","unstructured":"Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A et al (2019) Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain. 142(9):2558\u20132571","journal-title":"Brain."},{"key":"2453_CR25","doi-asserted-by":"publisher","first-page":"8602690","DOI":"10.1155\/2017\/8602690","volume":"2017","author":"M Yamasaki","year":"2017","unstructured":"Yamasaki M, Takeuchi T (2017) Locus coeruleus and dopamine-dependent memory consolidation. Neural Plast 2017:8602690","journal-title":"Neural Plast"},{"issue":"5","key":"2453_CR26","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.neuron.2018.04.030","volume":"98","author":"CM Teixeira","year":"2018","unstructured":"Teixeira CM, Rosen ZB, Suri D, Sun Q, Hersh M, Sargin D et al (2018) Hippocampal 5-HT input regulates memory formation and Schaffer collateral excitation. Neuron 98(5):992\u20131004.e4","journal-title":"Neuron"},{"key":"2453_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2018.05.006","volume":"680","author":"MJ Sekeres","year":"2018","unstructured":"Sekeres MJ, Winocur G, Moscovitch M (2018) The hippocampus and related neocortical structures in memory transformation. Neurosci Lett 680:39\u201353","journal-title":"Neurosci Lett"},{"issue":"5","key":"2453_CR28","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1111\/ejn.14089","volume":"48","author":"N Solari","year":"2018","unstructured":"Solari N, Hangya B (2018) Cholinergic modulation of spatial learning, memory and navigation. Eur J Neurosci 48(5):2199\u20132230","journal-title":"Eur J Neurosci"},{"issue":"2","key":"2453_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.expneurol.2008.11.021","volume":"216","author":"J Lockrow","year":"2009","unstructured":"Lockrow J, Prakasam A, Huang P, Bimonte-Nelson H, Sambamurti K, Granholm AC (2009) Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp Neurol 216(2):278\u2013289","journal-title":"Exp Neurol"},{"key":"2453_CR30","doi-asserted-by":"crossref","unstructured":"Hunter CL, Bimonte-Nelson HA, Nelson M, Eckman CB, Granholm AC (2004) Behavioral and neurobiological markers of Alzheimer' s disease in Ts65Dn mice: effects of estrogen. Neurobiol Aging 25(7):873\u2013884","DOI":"10.1016\/j.neurobiolaging.2003.10.010"},{"key":"2453_CR31","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","volume":"93","author":"DM Holtzman","year":"1996","unstructured":"Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K et al (1996) Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci U S A 93:13333\u201313338","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2453_CR32","doi-asserted-by":"crossref","unstructured":"Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, Carlson EJ et al (2001) Failed retrograde transport of NGF in a mouse model of Down' s syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A 98(18):10439\u201310444","DOI":"10.1073\/pnas.181219298"},{"key":"2453_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.neuroscience.2016.11.001","volume":"340","author":"BE Powers","year":"2017","unstructured":"Powers BE, Kelley CM, Velazquez R, Ash JA, Strawderman MS, Alldred MJ, Ginsberg SD, Mufson EJ et al (2017) Maternal choline supplementation in a mouse model of Down syndrome: effects on attention and nucleus basalis\/substantia innominata neuron morphology in adult offspring. Neuroscience. 340:501\u2013514","journal-title":"Neuroscience."},{"key":"2453_CR34","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1007\/s00429-015-1164-y","volume":"221","author":"BE Powers","year":"2016","unstructured":"Powers BE, Velazquez R, Kelley CM, Ash JA, Strawderman MS, Alldred MJ, Ginsberg SD, Mufson EJ et al (2016) Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome. Brain Struct Funct 221:4337\u20134352","journal-title":"Brain Struct Funct"},{"key":"2453_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nbd.2014.06.001","volume":"70","author":"JA Ash","year":"2014","unstructured":"Ash JA, Velazquez R, Kelley CM, Powers BE, Ginsberg SD, Mufson EJ, Strupp BJ (2014) Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice. Neurobiol Dis 70:32\u201342","journal-title":"Neurobiol Dis"},{"key":"2453_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/1567205012666150921100515","volume":"13","author":"CM Kelley","year":"2016","unstructured":"Kelley CM, Ash JA, Powers BE, Velazquez R, Alldred MJ, Ikonomovic MD, Ginsberg SD, Strupp BJ et al (2016) Effects of maternal choline supplementation on the septohippocampal cholinergic system in the Ts65Dn mouse model of Down syndrome. Curr Alzheimer Res 13:84\u201396","journal-title":"Curr Alzheimer Res"},{"key":"2453_CR37","doi-asserted-by":"crossref","unstructured":"Strupp BJ, Powers BE, Velazquez R, Ash JA, Kelley CM, Alldred MJ, Strawderman M, Caudill MA et al (2016) Maternal choline supplementation: a potential prenatal treatment for Down syndrome and Alzheimer' s disease. Curr Alzheimer Res 13:97\u2013106","DOI":"10.2174\/1567205012666150921100311"},{"key":"2453_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1037\/a0019590","volume":"124","author":"J Moon","year":"2010","unstructured":"Moon J, Chen M, Gandhy SU, Strawderman M, Levitsky DA, Maclean KN, Strupp BJ (2010) Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome. Behav Neurosci 124:346\u2013361","journal-title":"Behav Neurosci"},{"issue":"2","key":"2453_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0166-4328(02)00275-9","volume":"138","author":"CL Hunter","year":"2003","unstructured":"Hunter CL, Bimonte HA, Granholm A-CE (2003) Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory. Behav Brain Res 138(2):121\u2013131","journal-title":"Behav Brain Res"},{"key":"2453_CR40","doi-asserted-by":"crossref","unstructured":"Kelley CM, Ginsberg SD, Alldred MJ, Strupp BJ, Mufson EJ (2019) Maternal choline supplementation alters basal forebrain cholinergic neuron gene expression in the Ts65Dn Mouse model of down syndrome. Dev Neurobiol 79(7):664\u2013683","DOI":"10.1002\/dneu.22700"},{"key":"2453_CR41","doi-asserted-by":"crossref","unstructured":"Cataldo AM, Petanceska S, Peterhoff CM, Terio NB, Epstein CJ, Villar A, Carlson EJ, Staufenbiel M et al (2003) App gene dosage modulates endosomal abnormalities of Alzheimer' s disease in a segmental trisomy 16 mouse model of Down syndrome. J Neurosci 23:6788\u20136792","DOI":"10.1523\/JNEUROSCI.23-17-06788.2003"},{"key":"2453_CR42","doi-asserted-by":"crossref","unstructured":"Hunter CL, Isacson O, Nelson M, Bimonte-Nelson H, Seo H, Lin L, Ford K, Kindy MS et al (2003) Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down' s syndrome. Neurosci Res 45(4):437\u2013445","DOI":"10.1016\/S0168-0102(03)00005-1"},{"key":"2453_CR43","doi-asserted-by":"crossref","unstructured":"Contestabile A, Fila T, Bartesaghi R, Ciani E (2006) Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down' s syndrome and related neurodegenerative diseases. J Neurochem 97(2):515\u2013526","DOI":"10.1111\/j.1471-4159.2006.03769.x"},{"key":"2453_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neurobiolaging.2017.05.002","volume":"57","author":"MM Ahmed","year":"2017","unstructured":"Ahmed MM, Block A, Tong S, Davisson MT, Gardiner KJ (2017) Age exacerbates abnormal protein expression in a mouse model of Down syndrome. Neurobiol Aging 57:120\u2013132","journal-title":"Neurobiol Aging"},{"key":"2453_CR45","doi-asserted-by":"crossref","unstructured":"Alldred MJ, Chao HM, Lee SH, Beilin J, Powers BE, Petkova E, Strupp BJ, Ginsberg SD (2018) CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer' s disease following maternal choline supplementation. Hippocampus. 28(4):251\u2013268","DOI":"10.1002\/hipo.22832"},{"key":"2453_CR46","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.nbd.2011.10.022","volume":"45","author":"MJ Alldred","year":"2012","unstructured":"Alldred MJ, Duff KE, Ginsberg SD (2012) Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol Dis 45:751\u2013762","journal-title":"Neurobiol Dis"},{"key":"2453_CR47","doi-asserted-by":"crossref","unstructured":"Ginsberg, SD (2010) Alterations in discrete glutamate receptor subunits in adult mouse dentate gyrus granule cells following perforant path transection. Anal Bioanal Chem 397:3349\u20133358","DOI":"10.1007\/s00216-010-3826-1"},{"key":"2453_CR48","doi-asserted-by":"crossref","unstructured":"Alldred MJ, Lee SH, Petkova E, Ginsberg SD (2015) Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer ' s disease (AD). Brain Struct Funct 220:2983\u20132996","DOI":"10.1007\/s00429-014-0839-0"},{"key":"2453_CR49","doi-asserted-by":"crossref","unstructured":"Alldred MJ, Chao HM, Lee SH, Beilin J, Powers BE, Petkova E, Strupp BJ, Ginsberg SD (2019) Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer' s disease. FASEB J 33(9):9871\u20139884","DOI":"10.1096\/fj.201802669RR"},{"key":"2453_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/107385849500100404","volume":"1","author":"J Eberwine","year":"1995","unstructured":"Eberwine J, Crino P, Dichter M (1995) Single-cell mRNA amplification: implications for basic and clinical neuroscience. Neuroscientist 1:200\u2013211","journal-title":"Neuroscientist"},{"issue":"21","key":"2453_CR51","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.1523\/JNEUROSCI.21-21-08310.2001","volume":"21","author":"J Eberwine","year":"2001","unstructured":"Eberwine J, Kacharmina JE, Andrews C, Miyashiro K, McIntosh T, Becker K, Barrett T, Hinkle D et al (2001) mRNA expression analysis of tissue sections and single cells. J Neurosci 21(21):8310\u20138314","journal-title":"J Neurosci"},{"key":"2453_CR52","doi-asserted-by":"crossref","unstructured":"Ginsberg SD, Crino PB, Hemby SE, Weingarten JA, Lee VM, Eberwine JH et al (1999) Predominance of neuronal mRNAs in individual Alzheimer' s disease senile plaques. Ann Neurol 45:174\u2013181","DOI":"10.1002\/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E"},{"key":"2453_CR53","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1023\/B:NERE.0000023593.77052.f7","volume":"29","author":"SD Ginsberg","year":"2004","unstructured":"Ginsberg SD, Elarova I, Ruben M, Tan F, Counts SE, Eberwine JH, Trojanowski JQ, Hemby SE et al (2004) Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res 29:1053\u20131064","journal-title":"Neurochem Res"},{"key":"2453_CR54","doi-asserted-by":"crossref","unstructured":"Baugh LR, Hill AA, Brown EL, Hunter CP (2001) Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res 29(5):e29\u2013e229","DOI":"10.1093\/nar\/29.5.e29"},{"issue":"3","key":"2453_CR55","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/jnr.10351","volume":"70","author":"V Colangelo","year":"2002","unstructured":"Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70(3):462\u2013473","journal-title":"J Neurosci Res"},{"issue":"5","key":"2453_CR56","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2144\/04375PF01","volume":"37","author":"A Dafforn","year":"2004","unstructured":"Dafforn A, Chen P, Deng G, Herrler M, Iglehart D, Koritala S, Lato S, Pillarisetty S et al (2004) Linear mRNA amplification from as little as 5 ng total RNA for global gene expression analysis. BioTechniques. 37(5):854\u2013857","journal-title":"BioTechniques."},{"key":"2453_CR57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jneumeth.2008.10.027","volume":"177","author":"MJ Alldred","year":"2009","unstructured":"Alldred MJ, Che S, Ginsberg SD (2009) Terminal continuation (TC) RNA amplification without second strand synthesis. J Neurosci Methods 177:381\u2013385","journal-title":"J Neurosci Methods"},{"key":"2453_CR58","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3390\/ijms9112091","volume":"9","author":"MJ Alldred","year":"2008","unstructured":"Alldred MJ, Che S, Ginsberg SD (2008) Terminal continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain. Int J Mol Sci 9:2091\u20132104","journal-title":"Int J Mol Sci"},{"key":"2453_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13059-015-0694-1","volume":"16","author":"W Zhang","year":"2015","unstructured":"Zhang W, Yu Y, Hertwig F, Thierry-Mieg J, Zhang W, Thierry-Mieg D, Wang J, Furlanello C et al (2015) Comparison of RNA-seq and microarray-based models for clinical endpoint prediction. Genome Biol 16:133","journal-title":"Genome Biol"},{"key":"2453_CR60","doi-asserted-by":"publisher","first-page":"138","DOI":"10.12659\/MSMBR.892101","volume":"20","author":"KJ Mantione","year":"2014","unstructured":"Mantione KJ, Kream RM, Kuzelova H, Ptacek R, Raboch J, Samuel JM, Stefano GB (2014) Comparing bioinformatic gene expression profiling methods: microarray and RNA-Seq. Med Sci Monit Basic Res 20:138\u2013142","journal-title":"Med Sci Monit Basic Res"},{"issue":"10","key":"2453_CR61","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s11427-013-4557-2","volume":"56","author":"Z Dong","year":"2013","unstructured":"Dong Z, Chen Y (2013) Transcriptomics: advances and approaches. Sci China Life Sci 56(10):960\u2013967","journal-title":"Sci China Life Sci"},{"issue":"1","key":"2453_CR62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10(1):57\u201363","journal-title":"Nat Rev Genet"},{"key":"2453_CR63","doi-asserted-by":"crossref","unstructured":"Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, Xu N, Wang X, Bodeau J et al (2009) mRNA-seq whole-transcriptome analysis of a single cell. Nat Methods 6(5):377\u2013382","DOI":"10.1038\/nmeth.1315"},{"key":"2453_CR64","doi-asserted-by":"crossref","unstructured":"Trombetta JJ, Gennert D, Lu D, Satija R, Shalek AK, Regev A (2014) Preparation of single-cell RNA-seq libraries for next generation sequencing. Curr Protoc Mol Biol 107:1\u201317","DOI":"10.1002\/0471142727.mb0422s107"},{"key":"2453_CR65","doi-asserted-by":"publisher","first-page":"388","DOI":"10.5483\/BMBRep.2015.48.7.218","volume":"48","author":"T Kim","year":"2015","unstructured":"Kim T, Lim CS, Kaang BK (2015) Cell type-specific gene expression profiling in brain tissue: comparison between TRAP. LCM RNA-seq BMB Rep 48:388\u2013394","journal-title":"LCM RNA-seq BMB Rep"},{"key":"2453_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fnmol.2017.00185","volume":"10","author":"S Farris","year":"2017","unstructured":"Farris S, Wang Y, Ward JM, Dudek SM (2017) Optimized method for robust transcriptome profiling of minute tissues using laser capture microdissection and low-input RNA-seq. Front Mol Neurosci 10:185","journal-title":"Front Mol Neurosci"},{"key":"2453_CR67","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","volume":"22","author":"A Duchon","year":"2011","unstructured":"Duchon A, Raveau M, Chevalier C, Nalesso V, Sharp AJ, Herault Y (2011) Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Mamm Genome 22:674\u2013684","journal-title":"Mamm Genome"},{"issue":"8","key":"2453_CR68","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer' s disease. Biochim Biophys Acta 1842(8):1240\u20131247","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2453_CR69","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH (2018) Mitochondria and mitochondrial cascades in Alzheimer' s disease. J Alzheimers Dis 62(3):1403\u20131416","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"2453_CR70","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G (2019) Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15(9):501\u2013518","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2453_CR71","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5114\/fn.2019.84828","volume":"57","author":"M Prendecki","year":"2019","unstructured":"Prendecki M, Florczak-Wyspianska J, Kowalska M, Ilkowski J, Grzelak T, Bialas K, Kozubski W, Dorszewska J (2019) APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer' s disease. Folia Neuropathol 57(2):106\u2013116","journal-title":"Folia Neuropathol"},{"issue":"5","key":"2453_CR72","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L (2016) Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol 34(5):525\u2013527","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2453_CR73","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK (2014) Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 15(2):R29","journal-title":"Genome Biol"},{"issue":"7","key":"2453_CR74","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47","journal-title":"Nucleic Acids Res"},{"key":"2453_CR75","volume-title":"AnnotationDbi: manipulation of SQLite-based annotations in bioconductor","author":"HCM Pages","year":"2019","unstructured":"Pages HCM Falcon, S.; Li, N. AnnotationDbi: manipulation of SQLite-based annotations in bioconductor. 2019."},{"key":"2453_CR76","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2105-6-199","volume":"6","author":"P Broberg","year":"2005","unstructured":"Broberg P (2005) A comparative review of estimates of the proportion unchanged genes and the false discovery rate. BMC Bioinform 6:199","journal-title":"BMC Bioinform"},{"key":"2453_CR77","unstructured":"Qiagen. https:\/\/www.qiagenbioinformatics.com\/products\/ingenuity-pathway-analysis. Accessed 29 Sept 2020"},{"issue":"4","key":"2453_CR78","first-page":"523","volume":"30","author":"A Kr\u00e4mer","year":"2013","unstructured":"Kr\u00e4mer A, Green J, Pollard J Jr, Tugendreich S (2013) Causal analysis approaches in ingenuity pathway analysis. Bioinformatics (Oxford, England) 30(4):523\u2013530","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"1","key":"2453_CR79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27\u201330","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2453_CR80","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2018","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J et al (2018) STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607\u2013DD13","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2453_CR81","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"key":"2453_CR82","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.biopsych.2010.05.030","volume":"68","author":"SD Ginsberg","year":"2010","unstructured":"Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, Wuu J, Chao MV et al (2010) Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer' s disease progression. Biol Psychiatry 68:885\u2013893","journal-title":"Biol Psychiatry"},{"key":"2453_CR83","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1073\/pnas.0908953107","volume":"107","author":"Y Jiang","year":"2010","unstructured":"Jiang Y, Mullaney KA, Peterhoff CM, Che S, Schmidt SD, Boyer-Boiteau A, Ginsberg SD, Cataldo AM et al (2010) Alzheimer' s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci U S A 107:1630\u20131635","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2453_CR84","first-page":"1","volume-title":"Applied Biosystems Product Guide","author":"ABI","year":"2004","unstructured":"ABI (2004) Guide to Performing relative quantitation of gene expression using real-time quantitative PCR. In: Applied Biosystems Product Guide, pp. 1\u201360"},{"key":"2453_CR85","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00335-011-9321-y","volume":"22","author":"X Sturgeon","year":"2011","unstructured":"Sturgeon X, Gardiner KJ (2011) Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions. Mamm Genome 22:261\u2013271","journal-title":"Mamm Genome"},{"key":"2453_CR86","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.neurobiolaging.2007.11.026","volume":"30","author":"Y Chen","year":"2009","unstructured":"Chen Y, Dyakin VV, Branch CA, Ardekani B, Yang D, Guilfoyle DN, Peterson J, Peterhoff C et al (2009) In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model. Neurobiol Aging 30:1453\u20131465","journal-title":"Neurobiol Aging"},{"key":"2453_CR87","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.scr.2018.01.019","volume":"27","author":"JH Birnbaum","year":"2018","unstructured":"Birnbaum JH, Wanner D, Gietl AF, Saake A, K\u00fcndig TM, Hock C, Nitsch RM, Tackenberg C (2018) Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-\u03b2 and tau pathology in iPSC-derived neurons from sporadic Alzheimer' s disease patients. Stem Cell Res 27:121\u2013130","journal-title":"Stem Cell Res"},{"key":"2453_CR88","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JAD-2010-100240","volume":"21","author":"N Rueda","year":"2010","unstructured":"Rueda N, Llorens-Martin M, Florez J, Valdizan E, Banerjee P, Trejo JL et al (2010) Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome. J Alzheimers Dis 21:277\u2013290","journal-title":"J Alzheimers Dis"},{"key":"2453_CR89","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnbeh.2015.00267","volume":"9","author":"B Souchet","year":"2015","unstructured":"Souchet B, Guedj F, Penke-Verdier Z, Daubigney F, Duchon A, Herault Y et al (2015) Pharmacological correction of excitation\/inhibition imbalance in Down syndrome mouse models. Front Behav Neurosci 9:267","journal-title":"Front Behav Neurosci"},{"key":"2453_CR90","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1523\/JNEUROSCI.5338-13.2014","volume":"34","author":"G Kaur","year":"2014","unstructured":"Kaur G, Sharma A, Xu W, Gerum S, Alldred MJ, Subbanna S, Basavarajappa BS, Pawlik M et al (2014) Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down' s syndrome. J Neurosci 34:5099\u20135106","journal-title":"J Neurosci"},{"issue":"3","key":"2453_CR91","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.neulet.2005.03.031","volume":"382","author":"AC Costa","year":"2005","unstructured":"Costa AC, Grybko MJ (2005) Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome. Neurosci Lett 382(3):317\u2013322","journal-title":"Neurosci Lett"},{"issue":"37","key":"2453_CR92","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1523\/JNEUROSCI.1766-04.2004","volume":"24","author":"AM Kleschevnikov","year":"2004","unstructured":"Kleschevnikov AM, Belichenko PV, Villar AJ, Epstein CJ, Malenka RC, Mobley WC (2004) Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci 24(37):8153\u20138160","journal-title":"J Neurosci"},{"issue":"12","key":"2453_CR93","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/S0028-3908(99)00083-0","volume":"38","author":"RJ Siarey","year":"1999","unstructured":"Siarey RJ, Carlson EJ, Epstein CJ, Balbo A, Rapoport SI, Galdzicki Z (1999) Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome. Neuropharmacology. 38(12):1917\u20131920","journal-title":"Neuropharmacology."},{"key":"2453_CR94","doi-asserted-by":"crossref","unstructured":"Siarey RJ, Stoll J, Rapoport SI, Galdzicki Z (1997) Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome. Neuropharmacology. 36(11-12):1549\u20131554","DOI":"10.1016\/S0028-3908(97)00157-3"},{"key":"2453_CR95","doi-asserted-by":"crossref","unstructured":"Block A, Ahmed MM, Rueda N, Hernandez MC, Martinez-Cue C, Gardiner KJ (2018) The GABAAalpha5-selective modulator, RO4938581, rescues protein anomalies in the Ts65Dn mouse model of Down syndrome. Neuroscience. 372:192\u2013212","DOI":"10.1016\/j.neuroscience.2017.12.038"},{"key":"2453_CR96","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/bph.12169","volume":"169","author":"D Colas","year":"2013","unstructured":"Colas D, Chuluun B, Warrier D, Blank M, Wetmore DZ, Buckmaster P, Garner CC, Heller HC (2013) Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down' s syndrome. Br J Pharmacol 169:963\u2013973","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2453_CR97","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.nbd.2011.10.009","volume":"45","author":"AM Kleschevnikov","year":"2012","unstructured":"Kleschevnikov AM, Belichenko PV, Gall J, George L, Nosheny R, Maloney MT, Salehi A, Mobley WC (2012) Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis 45(2):683\u2013691","journal-title":"Neurobiol Dis"},{"key":"2453_CR98","doi-asserted-by":"crossref","unstructured":"Sriroopreddy R, Sajeed R, Raghuraman, P, Sudandiradoss, C (2019) Differentially expressed gene (DEG) based protein-protein interaction (PPI) network identifies a spectrum of gene interactome, transcriptome and correlated miRNA in nondisjunction Down syndrome. Int J Biol Macromol 122:1080\u20131089","DOI":"10.1016\/j.ijbiomac.2018.09.056"},{"issue":"1","key":"2453_CR99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cne.23663","volume":"523","author":"MJ Alldred","year":"2015","unstructured":"Alldred MJ, Lee SH, Petkova E, Ginsberg SD (2015) Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice. J Comp Neurol 523(1):61\u201374","journal-title":"J Comp Neurol"},{"key":"2453_CR100","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jchemneu.2011.02.004","volume":"42","author":"SE Counts","year":"2011","unstructured":"Counts SE, Che S, Ginsberg SD, Mufson EJ (2011) Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer' s disease. J Chem Neuroanat 42:111\u2013117","journal-title":"J Chem Neuroanat"},{"key":"2453_CR101","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.20233","volume":"56","author":"SE Counts","year":"2004","unstructured":"Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ (2004) Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer' s disease. Ann Neurol 56:520\u2013531","journal-title":"Ann Neurol"},{"key":"2453_CR102","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1471-4159.2006.03764.x","volume":"97","author":"SD Ginsberg","year":"2006","unstructured":"Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ (2006) Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer' s disease. J Neurochem 97:475\u2013487","journal-title":"J Neurochem"},{"key":"2453_CR103","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fncel.2017.00068","volume":"11","author":"V Latina","year":"2017","unstructured":"Latina V, Caioli S, Zona C, Ciotti MT, Amadoro G, Calissano P (2017) Impaired NGF\/TrkA signaling causes early AD-linked presynaptic dysfunction in cholinergic primary neurons. Front Cell Neurosci 11:68","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"2453_CR104","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00001756-199612200-00006","volume":"8","author":"EJ Mufson","year":"1996","unstructured":"Mufson EJ, Li JM, Sobreviela T, Kordower JH (1996) Decreased trkA gene expression within basal forebrain neurons in Alzheimer' s disease. Neuroreport. 8(1):25\u201329","journal-title":"Neuroreport."},{"key":"2453_CR105","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jchemneu.2011.05.012","volume":"42","author":"SD Ginsberg","year":"2011","unstructured":"Ginsberg SD, Mufson EJ, Alldred MJ, Counts SE, Wuu J, Nixon RA, Che S (2011) Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer' s disease. J Chem Neuroanat 42:102\u2013110","journal-title":"J Chem Neuroanat"},{"key":"2453_CR106","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1023\/A:1020952704398","volume":"27","author":"EJ Mufson","year":"2002","unstructured":"Mufson EJ, Counts SE, Ginsberg SD (2002) Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer' s disease. Neurochem Res 27:1035\u20131048","journal-title":"Neurochem Res"},{"key":"2453_CR107","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fnins.2019.00533","volume":"13","author":"EJ Mufson","year":"2019","unstructured":"Mufson EJ, Counts SE, Ginsberg SD, Mahady L, Perez SE, Massa SM, Longo FM, Ikonomovic MD (2019) Nerve growth factor pathobiology during the progression of Alzheimer' s disease. Front Neurosci 13:533","journal-title":"Front Neurosci"},{"key":"2453_CR108","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0891-0618(03)00068-1","volume":"26","author":"EJ Mufson","year":"2003","unstructured":"Mufson EJ, Ginsberg SD, Ikonomovic MD, DeKosky ST (2003) Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26:233\u2013242","journal-title":"J Chem Neuroanat"},{"issue":"3","key":"2453_CR109","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/cne.903510303","volume":"351","author":"AI Levey","year":"1995","unstructured":"Levey AI, Edmunds SM, Hersch SM, Wiley RG, Heilman CJ (1995) Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat. J Comp Neurol 351(3):339\u2013356","journal-title":"J Comp Neurol"},{"key":"2453_CR110","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuroscience.2017.06.019","volume":"357","author":"A Fajardo-Serrano","year":"2017","unstructured":"Fajardo-Serrano A, Liu L, Mott DD, McDonald AJ (2017) Evidence for M2 muscarinic receptor modulation of axon terminals and dendrites in the rodent basolateral amygdala: an ultrastructural and electrophysiological analysis. Neuroscience. 357:349\u2013362","journal-title":"Neuroscience."},{"key":"2453_CR111","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fphys.2016.00621","volume":"7","author":"E Khaziev","year":"2016","unstructured":"Khaziev E, Samigullin D, Zhilyakov N, Fatikhov N, Bukharaeva E, Verkhratsky A et al (2016) Acetylcholine-induced inhibition of presynaptic calcium signals and transmitter release in the frog neuromuscular junction. Front Physiol 7:621","journal-title":"Front Physiol"},{"issue":"5","key":"2453_CR112","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00401-013-1103-z","volume":"125","author":"J Lee","year":"2013","unstructured":"Lee J, Hwang YJ, Shin JY, Lee WC, Wie J, Kim KY, Lee MY, Hwang D et al (2013) Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington' s disease. Acta Neuropathol 125(5):727\u2013739","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2453_CR113","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1073\/pnas.93.4.1391","volume":"93","author":"E Dippel","year":"1996","unstructured":"Dippel E, Kalkbrenner F, Wittig B, Schultz G (1996) A heterotrimeric G protein complex couples the muscarinic m1 receptor to phospholipase C-beta. Proc Natl Acad Sci U S A 93(4):1391\u20131396","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2453_CR114","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/path.2912","volume":"225","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2011) Deficient brain insulin signalling pathway in Alzheimer' s disease and diabetes. J Pathol 225(1):54\u201362","journal-title":"J Pathol"},{"issue":"7","key":"2453_CR115","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1073\/pnas.90.7.2628","volume":"90","author":"K Saito","year":"1993","unstructured":"Saito K, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 90(7):2628\u20132632","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2453_CR116","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-018-0279-z","volume":"13","author":"B Becker","year":"2018","unstructured":"Becker B, Nazir FH, Brinkmalm G, Camporesi E, Kvartsberg H, Portelius E, Bostr\u00f6m M, Kalm M et al (2018) Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase. Mol Neurodegener 13(1):47","journal-title":"Mol Neurodegener"},{"issue":"16","key":"2453_CR117","doi-asserted-by":"publisher","first-page":"7123","DOI":"10.1021\/acs.jmedchem.7b00731","volume":"60","author":"A Kling","year":"2017","unstructured":"Kling A, Jantos K, Mack H, Hornberger W, Drescher K, Nimmrich V, Relo A, Wicke K et al (2017) Discovery of novel and highly selective inhibitors of calpain for the treatment of Alzheimer' s disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides. J Med Chem 60(16):7123\u20137138","journal-title":"J Med Chem"},{"issue":"1-2","key":"2453_CR118","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0006-8993(02)03280-8","volume":"953","author":"HJ L\u00fcth","year":"2002","unstructured":"L\u00fcth HJ, M\u00fcnch G, Arendt T (2002) Aberrant expression of NOS isoforms in Alzheimer' s disease is structurally related to nitrotyrosine formation. Brain Res 953(1-2):135\u2013143","journal-title":"Brain Res"},{"issue":"2","key":"2453_CR119","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/cercor\/bhh123","volume":"15","author":"HJ L\u00fcth","year":"2005","unstructured":"L\u00fcth HJ, Ogunlade V, Kuhla B, Kientsch-Engel R, Stahl P, Webster J, Arendt T, M\u00fcnch G (2005) Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer' s disease brains. Cereb Cortex 15(2):211\u2013220","journal-title":"Cereb Cortex"},{"key":"2453_CR120","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fnagi.2017.00087","volume":"9","author":"WJ Lukiw","year":"2017","unstructured":"Lukiw WJ, Rogaev EI (2017) Genetics of aggression in Alzheimer' s disease (AD). Front Aging Neurosci 9:87","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2453_CR121","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JAD-2010-1375","volume":"20","author":"DA Butterfield","year":"2010","unstructured":"Butterfield DA, Hardas SS, Lange ML (2010) Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer' s disease: many pathways to neurodegeneration. J Alzheimers Dis 20(2):369\u2013393","journal-title":"J Alzheimers Dis"},{"key":"2453_CR122","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.12659\/MSM.905064","volume":"23","author":"WS Chang","year":"2017","unstructured":"Chang WS, Wang YH, Zhu XT, Wu CJ (2017) Genome-wide profiling of miRNA and mRNA expression in Alzheimer' s disease. Med Sci Monit 23:2721\u20132731","journal-title":"Med Sci Monit"},{"issue":"6286","key":"2453_CR123","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352(6286):712\u2013716","journal-title":"Science"},{"issue":"11-12","key":"2453_CR124","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00335-016-9661-8","volume":"27","author":"M Gupta","year":"2016","unstructured":"Gupta M, Dhanasekaran AR, Gardiner KJ (2016) Mouse models of Down syndrome: gene content and consequences. Mamm Genome 27(11-12):538\u2013555","journal-title":"Mamm Genome"},{"key":"2453_CR125","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fnbeh.2015.00268","volume":"9","author":"XY Choong","year":"2015","unstructured":"Choong XY, Tosh JL, Pulford LJ, Fisher EM (2015) Dissecting Alzheimer disease in Down syndrome using mouse models. Front Behav Neurosci 9:268","journal-title":"Front Behav Neurosci"},{"key":"2453_CR126","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0378-1119(03)00769-8","volume":"318","author":"K Gardiner","year":"2003","unstructured":"Gardiner K, Fortna A, Bechtel L, Davisson MT (2003) Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene. 318:137\u2013147","journal-title":"Gene."},{"key":"2453_CR127","first-page":"103","volume":"9","author":"KJ Gardiner","year":"2015","unstructured":"Gardiner KJ (2015) Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations. Drug Des Devel Ther 9:103\u2013125","journal-title":"Drug Des Devel Ther"},{"key":"2453_CR128","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejpn.2007.08.010","volume":"12","author":"M Rachidi","year":"2008","unstructured":"Rachidi M, Lopes C (2008) Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways. Eur J Paediatr Neurol 12:168\u2013182","journal-title":"Eur J Paediatr Neurol"},{"key":"2453_CR129","doi-asserted-by":"crossref","unstructured":"Rueda N, Florez J, Martinez-Cue C (2012) Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities. Neural Plast 2012:584071","DOI":"10.1155\/2012\/584071"}],"updated-by":[{"DOI":"10.1007\/s12035-021-02647-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02453-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T22:21:02Z","timestamp":1675549262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02453-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":129,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2453"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02453-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-88218\/v1","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]},"assertion":[{"value":"29 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12035-021-02647-9","URL":"https:\/\/doi.org\/10.1007\/s12035-021-02647-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal protocols were approved by the Nathan Kline Institute\/NYU Grossman \u00a0 School of Medicine Animal Care and Use Committee (IACUC) in accordance with NIH guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}